In the last year alone, the pharmaceutical sector has witnessed phenomenal changes. The rush for a potent vaccine in the wake of the pandemic made it imperative for organizations to bolster their capabilities and foster robust partnerships. In this background, many pharma organizations started enhancing their production by partnering with market-leading contract manufacturing organizations (CMOs). Multiple factors like tight timelines, cost-reductions, and quality standards began prompting pharma organizations to turn to CMOs. And to keep up with this evolution, CMOs are now investing in robust technologies to shore up their capabilities.
CMOs that are on the helm of digitalization are already integrating emerging technologies and unlocking the benefits or reduced costs and risks associated with drug manufacturing, while achieving unprecedented levels of efficiency and productivity for their pharma partners. Specifically, robotic process automation (RPA), AI, and machine learning are turning out to be key factors that are empowering CMOs to meet the evolving requirements of the pharmaceutical sector. Whether it is automating back-office tasks or process-oriented operations, CMOs are increasingly adopting emerging technologies to streamline their drug production processes.
To assist pharmaceutical organizations in the task of finding the most accomplished CMOs, we have compiled this issue of Pharma Tech Outlook. It is elaborately crafted to assist you in fostering productive partnerships and improving performance. In this edition, we have listed the top 10 CMOs to highlight those making significant contributions to the pharmaceutical sector. Equipped with innovative technological capabilities, these CMOs are set to transform the landscape. This edition also blends thought leadership articles from subject-matter experts and CXOs. We hope this issue of Pharma Tech Outlook helps you build the partnership you and your organization need to foster a workspace driven by robust and efficient technology.
We present to you Pharma Tech Outlook’s, “Top 10 CMOs - 2021.”
